Severe Thrombocytopenia in COVID-19: A Conundrum in Dengue-endemic Areas

Thrombocytopenia in coronavirus disease-2019 (COVID-19) can be attributed to multiple factors. Most often it is disease related. It is usually mild and if severe often associated with severe COVID-19 disease. It can also be due to drugs (Remdesivir, Tocilizumab) or coinfection with other viruses. He...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine official publication of Indian Society of Critical Care Medicine, 2021, Vol.25 (4), p.465-466
Main Authors: Adarsh, M B, Abraham, Anitha, Kavitha, P, Nandakumar, Meera M, Vaman, Raman S
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Thrombocytopenia in coronavirus disease-2019 (COVID-19) can be attributed to multiple factors. Most often it is disease related. It is usually mild and if severe often associated with severe COVID-19 disease. It can also be due to drugs (Remdesivir, Tocilizumab) or coinfection with other viruses. Here we report two cases of severe thrombocytopenia in COVID-19 due to dengue coinfection. Most often the thrombocytopenia in dengue is self-resolving, and a careful "wait and watch" should suffice unlike COVID-19, where steroids can help if the cytopenia is due to cytokine storm or immune-mediated effects. HOW TO CITE THIS ARTICLEAdarsh MB, Abraham A, Kavitha P, Nandakumar MM, Vaman RS. Severe Thrombocytopenia in COVID-19: A Conundrum in Dengue-endemic Areas. Indian J Crit Care Med 2021;25(4):465-466.
ISSN:0972-5229
DOI:10.5005/jp-journals-10071-23778